Roster of the Molecular and Clinical Genetics Panel
Purpose: The Committee reviews and evaluates data concerning the safety and effectiveness of marketed and investigational in vitro devices for use in clinical laboratory medicine including clinical and molecular genetics and makes appropriate recommendations to the Commissioner of Food and Drugs.
As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.
Current Number of Vacancies: 1
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.
Ronald M. Przygodzki, M.D.
Expertise: Molecular Genetics
Term: 02/10/2014 – 05/31/2017
Acting Director, Biomedical Laboratory
Research & Development
Dept. of Veterans Affairs, Office of Research & Development
810 Vermont Ave., NW (121E)
Washington, DC 20420
|Designated Federal Official|
Center for Devices and Radiological Health
Office of Device Evaluation
10903 New Hampshire Ave.
WO Bldg. 66, Room #1544
Silver Spring, MD 20993
Christopher M. Cunniff, M.D.
Luis F. Escobar, MD
David B. Flannery, M.D.
Expertise: Neuromuscular Disorders
Term: 02/14/2012 - 05/31/2015
Founding President and CEO
Parent Project Muscular Dystrophy
1052 North University
Middletown, OH 45042
**David W. Gates, Ph.D.
Richard D. Press, M.D., Ph.D.
Expertise: Molecular Genetics; Human Genetics
Term: 06/01/2011 - 05/31/2015
Director Molecular Genetics
Dept. of Pathology & Lab Medicine
Univ. of North Carolina School of Medicine
101 Manning Drive, Campus Box 7525
Chapel Hill, NC 27599-7525